Shearman & Sterling represented J.P. Morgan, Morgan Stanley, RBC Capital Markets, BoA Merrill Lynch and Wells Fargo Securities as underwriters of Catalent, Inc’s follow-on equity offering of 11,431,411 shares of common stock (including the full exercise of the underwriters’ option to purchase 1,491,053 additional shares) at a public offering price of $40.24 per share. Catalent expects to use the net proceeds from the offering to repay a corresponding portion of the outstanding borrowings under its USD term loans.

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer and animal health products.